1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. GlaxoSmithKline Pharmaceuticals Limited
  6. News
  7. Summary
    500660   INE159A01016

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

(500660)
  Report
End-of-day quote Bombay Stock Exchange  -  05-18
1523.80 INR   -0.15%
05/17GlaxoSmithKline Pharmaceuticals Limited announces results for the full year ended March 31, 2022
AQ
05/17GlaxoSmithKline Pharmaceuticals Sees Surge in Fiscal Q4 Consolidated Net Profit
MT
05/16GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Manu Anand as Additional Independent Director
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

GlaxoSmithKline Pharmaceuticals' Consolidated Net Profit Nearly Triples in Fiscal Q2

11/02/2021 | 05:05am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED -0.15% 1523.8 End-of-day quote.-13.45%
GLAXOSMITHKLINE PLC 2.03% 1766.4 Delayed Quote.7.78%
All news about GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
05/17GlaxoSmithKline Pharmaceuticals Limited announces results for the full year ended March..
AQ
05/17GlaxoSmithKline Pharmaceuticals Sees Surge in Fiscal Q4 Consolidated Net Profit
MT
05/16GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Manu Anand as Addition..
CI
05/16Glaxosmithkline Pharmaceuticals Limited Recommends Special Dividend for the Year Ended ..
CI
05/16GlaxoSmithKline Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31..
CI
05/16GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter..
CI
05/16GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Full Year Ende..
CI
04/21GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as Chief F..
CI
04/21GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as A Whole..
CI
03/16GlaxoSmithKline Pharmaceuticals Completes Transfer of Two Drugs to GlaxoSmithKline Asia
MT
More news
Financials
Sales 2022 34 314 M 443 M 443 M
Net income 2022 11 084 M 143 M 143 M
Net cash 2022 9 694 M 125 M 125 M
P/E ratio 2022 24,6x
Yield 2022 2,97%
Capitalization 258 B 3 332 M 3 332 M
EV / Sales 2022 7,24x
EV / Sales 2023 6,91x
Nbr of Employees 4 283
Free-Float 24,5%
Chart GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Duration : Period :
GlaxoSmithKline Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 1 523,80 INR
Average target price 1 642,57 INR
Spread / Average Target 7,79%
EPS Revisions
Managers and Directors
Sridhar Venkatesh Managing Director & Director
Juby Chandy Chief Financial Officer & Director
Renu Sud Karnad Non-Executive Chairman
Priyanka Bhatia Head-Medical Affairs
Ajay A. Nadkarni Secretary & Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-13.45%3 332
JOHNSON & JOHNSON2.59%457 706
PFIZER, INC.-14.23%284 192
ABBVIE INC.12.05%268 106
ROCHE HOLDING AG-16.41%265 188
ELI LILLY AND COMPANY3.64%257 689